Spoken Alpha
KALV
KalVista Pharmaceuticals, Inc.
Overview
KalVista Pharmaceuticals, Inc is a Healthcare company operating in Biotechnology with a $1.44B market cap.
Most recent reported earnings: Q1 FY2027 (Aug 12, 2026).
3 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q1 FY20272026-08-12EPS— vs $-0.29—Rev— vs ——EODHD
- Q4 FY20262026-04-29EPS$-0.43 vs $-0.38-14.3%Rev$59.9M vs ——EODHD
- Q3 FY20262026-08-12EPS— vs $-0.29—Rev— vs ——EODHD
- Q2 FY20262025-12-10EPS$-0.92 vs $-0.91-1.1%Rev$40.9M vs ——EODHD
- Q1 FY20262025-09-02EPS$-1.12 vs $-0.90-24.4%Rev$1.4M vs ——EODHD
- Q4 FY20252025-07-09EPS$-0.99 vs $-0.81-22.2%Rev$0 vs ——EODHD
- Q3 FY20252025-03-11EPS$-0.92 vs $-0.87-5.8%Rev$0 vs ——EODHD
- Q2 FY20252024-12-03EPS$-0.91 vs $-0.910.0%Rev$0 vs ——EODHD
- Q1 FY20252026-03-24EPS$0.94 vs $-0.53+100.0%Rev$40.9M vs ——EODHD
- Q4 FY20242024-07-10EPS$-1.02 vs $-0.73-39.7%Rev$1.2M vs ——EODHD
- Q3 FY20242024-03-10EPS$-0.84 vs $-0.80-5.0%Rev$0 vs ——EODHD
- Q2 FY20242023-12-06EPS$-0.80 vs $-0.78-2.6%Rev$0 vs ——EODHD
- Q1 FY20242023-09-06EPS$-0.74 vs $-0.84+11.9%Rev$0 vs ——EODHD
- Q4 FY20232023-07-06EPS$-0.77 vs $-0.94+18.1%Rev$0 vs ——EODHD
- Q3 FY20232023-03-08EPS$-0.75 vs $-1.00+25.0%Rev$0 vs ——EODHD
- Q2 FY20232022-12-07EPS$-0.90 vs $-1.05+14.3%Rev$0 vs ——EODHD
- Q1 FY20232022-09-07EPS$-0.94 vs $-0.97+3.1%Rev$0 vs ——EODHD
- Q4 FY20222022-07-06EPS$-0.98 vs $-1.09+10.1%Rev$0 vs ——EODHD
- Q3 FY20222022-03-09EPS$-0.92 vs $-0.90-2.2%Rev$0 vs ——EODHD
- Q2 FY20222021-12-08EPS$-0.80 vs $-0.75-6.7%Rev$0 vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 2026-08-12 | — | $-0.29 | — | — | — | — | EODHD |
| Q4 FY2026 | 2026-04-29 | $-0.43 | $-0.38 | -14.3% | $59.9M | — | — | EODHD |
| Q3 FY2026 | 2026-08-12 | — | $-0.29 | — | — | — | — | EODHD |
| Q2 FY2026 | 2025-12-10 | $-0.92 | $-0.91 | -1.1% | $40.9M | — | — | EODHD |
| Q1 FY2026 | 2025-09-02 | $-1.12 | $-0.90 | -24.4% | $1.4M | — | — | EODHD |
| Q4 FY2025 | 2025-07-09 | $-0.99 | $-0.81 | -22.2% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-03-11 | $-0.92 | $-0.87 | -5.8% | $0 | — | — | EODHD |
| Q2 FY2025 | 2024-12-03 | $-0.91 | $-0.91 | 0.0% | $0 | — | — | EODHD |
| Q1 FY2025 | 2026-03-24 | $0.94 | $-0.53 | +100.0% | $40.9M | — | — | EODHD |
| Q4 FY2024 | 2024-07-10 | $-1.02 | $-0.73 | -39.7% | $1.2M | — | — | EODHD |
| Q3 FY2024 | 2024-03-10 | $-0.84 | $-0.80 | -5.0% | $0 | — | — | EODHD |
| Q2 FY2024 | 2023-12-06 | $-0.80 | $-0.78 | -2.6% | $0 | — | — | EODHD |
| Q1 FY2024 | 2023-09-06 | $-0.74 | $-0.84 | +11.9% | $0 | — | — | EODHD |
| Q4 FY2023 | 2023-07-06 | $-0.77 | $-0.94 | +18.1% | $0 | — | — | EODHD |
| Q3 FY2023 | 2023-03-08 | $-0.75 | $-1.00 | +25.0% | $0 | — | — | EODHD |
| Q2 FY2023 | 2022-12-07 | $-0.90 | $-1.05 | +14.3% | $0 | — | — | EODHD |
| Q1 FY2023 | 2022-09-07 | $-0.94 | $-0.97 | +3.1% | $0 | — | — | EODHD |
| Q4 FY2022 | 2022-07-06 | $-0.98 | $-1.09 | +10.1% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-03-09 | $-0.92 | $-0.90 | -2.2% | $0 | — | — | EODHD |
| Q2 FY2022 | 2021-12-08 | $-0.80 | $-0.75 | -6.7% | $0 | — | — | EODHD |
Source: EODHD. KALV reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Benjamin L PalleikoCEO2 yr 6 mo3 callsCurrent
- Brian PiekosCFO2 yr3 callsCurrent
- Bilal ArifChief Operations Officer11 mono recorded callsCurrent
- Nicole SweenyChief Commercial Officer1 yr 3 mo3 callsCurrent
- Christopher YeaCHIEF DEVELOPMENT OFFICER2 yr 7 mono recorded callsCurrent
- Paul K AudhyaCHIEF MEDICAL OFFICER2 yr 7 mo3 callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for KALV.
$ curl https://api.spokenalpha.com/v1/companies/KALVFAQ
Frequently asked about KALV
Where can I find KalVista Pharmaceuticals, Inc.'s (KALV) earnings call transcripts?
Spoken Alpha indexes KALV's earnings call transcripts at https://spokenalpha.com/companies/KALV. Each call links to attributed speakers and parsed analyst Q&A.
When was KalVista Pharmaceuticals, Inc.'s most recent earnings call?
KalVista Pharmaceuticals, Inc. (KALV) held its most recent earnings call on 2026-03-25, covering fiscal Q1 2025.
What sector is KALV in?
KalVista Pharmaceuticals, Inc. (KALV) operates in the Healthcare sector (Biotechnology industry).